Exact Mass: 366.1807306
Exact Mass Matches: 366.1807306
Found 101 metabolites which its exact mass value is equals to given mass value 366.1807306
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2,2-Dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetate
17-(Trifluorovinyl)-3-(methyl ether)-17beta-estradiol
C21H25F3O2 (366.18065459999997)
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside is found in fats and oils. (1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside is a constituent of fruit of Carum carvi (caraway). Constituent of fruit of Carum carvi (caraway). (1S,2S,4R,8R)-p-Menthane-1,2,8,9-tetrol 2-glucoside is found in fats and oils and herbs and spices.
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is found in fats and oils. (1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is a constituent of fruit of Carum carvi (caraway). Constituent of fruit of Carum carvi (caraway). (1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is found in fats and oils and herbs and spices.
Bufotenine O-glucoside
Bufotenine O-glucoside is found in citrus. Bufotenine O-glucoside is an alkaloid from the leaves of Citrus unshiu (satsuma mandarin
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is found in herbs and spices. (2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). (2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is found in herbs and spices.
3-Geranyl-2,4,6-trihydroxybenzophenone
A member of the class of benzophenones that is benzophenone substituted by a geranyl group at position 3 and hydroxy groups at positions 2, 4 and 6 respectively. Isolated from Leontonyx and Garcinia vieillardii, it exhibits a significant antileishmanial activity.
2-{2-benzimidazol-2-yl-1-[(4-methylphenyl)methyl]ethyl}benzimidazole
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.970 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.963 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.961
Dicarboxyl-2But-A6EO4
Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); Could be alkyl homologue of given structure; Digitised from figure: approximate intensities
[3-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxyphenyl]phenylmethanone
Me glycoside,penta-Me-beta-Pyranose-3-O-beta-D-Xylopyranosyl-D-xylose
(+/-)-trans-3-(4-hydroxy-3-methoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene
Hexa-Me-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-xylose
(E)-(2-(3,7-dimethylocta-2,6-dienyloxy)-4,6-dihydroxyphenyl)(phenyl)methanone|2-geranyloxy-4,6-dihydroxybenzophenone|elegaphenone
(3R,5R)-3-O-beta-D-mannosyl-3,5-dihydrodecanoic acid
3-[3-hydroxy-4-(3-methylbut-2-enyl)phenyl]-5-(4-hydroxybenzyl)-4-methyldihydrofuran-2(3H)-one
3,7-dimethyloct-3(10)-ene-1,2,6,7-tetrol 7-O-beta-D-glucopyranoside
Methyl glycoside,penta-Me-beta-Pyranose -Xylobiose
12,15-sulfonyl-8(17),13-labdadien-19-oic acid
C20H30O4S (366.18647000000004)
2-Methyl-2-<4,4-dimethylpent-3-en-yl>-5,7-dihydroxy-6-benzoyl chroman
(2S,6zeta)-3,7-dimethyloct-3(10)-ene-1,2,6,7-tetrol 1-O-beta-D-glucopyranoside|(2S,6?卢)-3,7-Dimethyloct-3(10)-ene-1,2,6,7-tetrol 1-O-??-D-glucopyranoside
Gly Pro Pro Pro
C17H26N4O5 (366.19031060000003)
Pro Gly Pro Pro
C17H26N4O5 (366.19031060000003)
Pro Pro Gly Pro
C17H26N4O5 (366.19031060000003)
Pro Pro Pro Gly
C17H26N4O5 (366.19031060000003)
Bufotenine O-glucoside
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(4-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
1,3-diisocyanato-2-methylbenzene,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,2-methyloxirane
hexanedioic acid,2-(2-hydroxyethoxy)ethanol,oxepan-2-one
(S)-TERT-BUTYL2-(HYDRAZINECARBONYL)PYRROLIDINE-1-CARBOXYLATE
4,5-diisocyanatobicyclo[4.1.0]hepta-1(6),2,4-triene,ethane-1,2-diamine,2-methyloxirane,propane-1,2-diol
C17H26N4O5 (366.19031060000003)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(2-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(3-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
Methylatropine nitrate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-[(4-methylphenyl)methyl]-N-propyl- (9CI)
C21H26N4S (366.18780760000004)
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(2-methylpropyl)-N-(phenylmethyl)- (9CI)
C21H26N4S (366.18780760000004)
Liafensine
C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor
Roluperidone
C22H23FN2O2 (366.17434699999995)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
1-(5-Oxo-2,3,5,9B-tetrahydro-1H-pyrrolo[2,1-A]isoindol-9-YL)-3-(5-pyrrolidin-2-YL-1H-pyrazol-3-YL)-urea
C19H22N6O2 (366.18041519999997)
2-(3,3-dimethyl-1-oxo-4,9-dihydro-2H-xanthen-9-yl)-5,5-dimethylcyclohexane-1,3-dione
L 152804 is an orally active and selective neuropeptide Y Y5 receptor (NPY5-R) antagonist, with a Ki of 26 nM for hY5. L 152804 causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure[1][2].
20,21,21-Trifluoro-3-methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol
C21H25F3O2 (366.18065459999997)
4-(6-Cyclohexylmethoxy-9H-purin-2-ylamino)--benzamide
C19H22N6O2 (366.18041519999997)
[2-(3-Fluorophenyl)-5-propyl-pyrazol-3-yl] 2-phenylbutanoate
C22H23FN2O2 (366.17434699999995)
N4-(2-furanylmethyl)-N2-(3-methylphenyl)-6-(4-morpholinyl)-1,3,5-triazine-2,4-diamine
C19H22N6O2 (366.18041519999997)
4-[3-(1-Naphthalenyl)prop-2-ynyl]-4-(3-phenylprop-2-ynyl)morpholin-4-ium
[(3aR,4R,9bR)-4-(hydroxymethyl)-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone
C22H23FN2O2 (366.17434699999995)
methyl 8-[(2E)-2-[(4-hydroxy-2,6-dimethoxyphenyl)methylidene]hydrazinyl]-8-oxooctanoate
(2-hydroxy-3-phosphonooxypropyl) (Z)-tridec-9-enoate
3-[3-hydroxy-4-(3-methylbut-2-en-1-yl)phenyl]-5-[(4-hydroxyphenyl)methyl]-4-methyloxolan-2-one
(3r,5r)-5-hydroxy-3-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}decanoic acid
1,4a-dimethyl-5-[(3-methyl-1,1-dioxo-2,5-dihydro-1λ⁶-thiophen-2-yl)methyl]-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
C20H30O4S (366.18647000000004)
(2r,3s,5s)-2-{[(6s)-6,7-dihydroxy-3,7-dimethyloct-1-en-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
4-benzoyl-5-[(3,7-dimethylocta-2,6-dien-1-yl)oxy]benzene-1,3-diol
(1s,4ar,5s,8ar)-1,4a-dimethyl-5-{[(2r)-3-methyl-1,1-dioxo-2,5-dihydro-1λ⁶-thiophen-2-yl]methyl}-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
C20H30O4S (366.18647000000004)